Description

Versartis, Inc. Versartis develops novel biologics with enhanced properties to provide a medical benefit to patients with metabolic disease. Versartis employs a novel recombinant half-life extension technology to target established biologics in well capitalized markets to ensure high value creation

Life Science Sector
Certificates
NO DATA